FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Taro Pharmaceuticals U.S.A. children's allergy relief Recall

children's allergy relief (cetirizine hydrochloride) oral solution, 1 mg/mL, Dye Free,…

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class II
Reported by FDA
Nov 21, 2018
Recall ID
D-0278-2019
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled children's allergy relief starting Oct 19, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0278-2019 on Nov 21, 2018. Reason: Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Product description

children's allergy relief (cetirizine hydrochloride) oral solution, 1 mg/mL, Dye Free, Sugar Free, Alcohol Free, 4 FL OZ (120 mL) bottle, Distributed by Rite-Aid, 30 Hunter Lane, Camp Hill, PA 17011, Made in Israel, UPC 0 11822 57363 4.

Lot numbers, UPCs & expiration codes

Lot # 313344, Exp 12/18

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0278-2019
Classification
Class II
Status
Terminated
Recall initiated
Oct 19, 2018
FDA report date
Nov 21, 2018
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-0278-2019, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
81483
Address
3 Skyline Dr
Code information
Lot # 313344, Exp 12/18
Postal code
10532-2174
Report date
Nov 21, 2018
Product type
Drugs
Recall number
D-0278-2019
Classification
Class II
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Termination date
Nov 3, 2020
Reason for recall
Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
children's allergy relief (cetirizine hydrochloride) oral solution, 1 mg/mL, Dye Free, Sugar Free, Alcohol Free, 4 FL OZ (120 mL) bottle, Distributed by Rite-Aid, 30 Hunter Lane, Camp Hill, PA 17011, Made in Israel, UPC 0 11822 57363 4.
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 19, 2018
Initial firm notification
Letter
Center classification date
Nov 20, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0278-2019, published Nov 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls